Novartis hands investors Alcon spin-off and $5 billion share buyback

ZURICH (Reuters) - Novartis plans to spin off its Alcon eye care business to shareholders and repurchase up to $5 billion in shares, as Chief Executive Vas Narasimhan refocuses the Swiss firm on prescription drugs.

from Reuters: Business News https://ift.tt/2IC3JOK